MANE
Veradermics, Incorporated
156.56
+7.56 (+5.07%)
52w low 32.00
152.82 high
100.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | -- | 16.07M | 19.82M | 22.75M | 29.71M | 29.55M | |
| R&D | -- | 14.33M | 18.10M | 18.19M | 20.93M | 18.61M | |
| SG&A | -- | 1.74M | 2.25M | 4.82M | 8.94M | 10.95M | |
| Operating Income | -- | -16.07M | -19.82M | -22.75M | -29.71M | -29.55M | |
| EBITDA | -- | -16.07M | -19.16M | -21.85M | -29.71M | -29.55M | |
| Pretax Income | -- | -15.64M | -20.10M | -21.85M | -27.23M | -23.50M | |
| Income Tax | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -- | -15.64M | -20.10M | -21.85M | -27.23M | -23.50M | |
| EPS Diluted | -0.73 | -0.51 | -- | -0.62 | -1.32 | -0.58 | |
| Diluted Shares | 19.91M | 35.08M | -- | 35.08M | 22.70M | 40.44M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--